VENTURE LIFE GROUP PLC — Director's Dealing 2017

Aug 7, 2017

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 3240N

Venture Life Group PLC

07 August 2017

7 August 2017

Venture Life Group plc

("Venture Life" or "the Company")

Director/PDMR Shareholding

Venture Life (AIM: VLG), the international consumer self-care group focused on developing, manufacturing and commercialising products for the ageing population, announces that it was notified on 7 August 2017 that Peter Bream, a Non-Executive Director of the Company, has purchased 25,000 ordinary shares of 0.3p each in the Company at an average price of 62.6p per share.  Following the transaction Mr Bream has a beneficial interest in 25,000 ordinary shares representing 0.07 per cent. of the Company's issued share capital. 

Enquiries:

Venture Life Group PLC			+44 (0) 1344 742870
Jerry Randall, Chief Executive Officer
Adrian Crockett, Chief Financial Officer
Northland Capital Partners Limited (Nominated Adviser and Joint Broker)			+44 (0) 20 3861 6625
Matthew Johnson / Edward Hutton / Margarita Mitropoulou (Corporate Finance)
Bob Pountney / John Howes (Corporate Broking)
Turner Pope Investments (TPI) Ltd (Joint Broker)			+44 (0) 20 3621 4120
James Pope / Ben Turner
Walbrook PR	venturelife@walbrookpr.com or  + 44 (0) 20 7933 8780
Paul McManus / Anna Dunphy		+44 (0) 7980 541 893 / +44 (0) 7876 741 001

About Venture Life (www.venture-life.com) 

Venture Life is an international consumer self-care company focused on developing, manufacturing and commercialising products for the ageing population. The Group's product portfolio includes some key products such as the UltraDEX oral care products range, food supplements for lowering cholesterol and maintaining brain function, medical devices for women's intimate healthcare and haemorrhoids and dermo-cosmetics for addressing the signs of ageing.

The products, which are typically recommended by pharmacists or healthcare practitioners, are available primarily through pharmacies supplied by the Group's international distribution partners.

Through its Development & Manufacturing business in Italy, Biokosmes, the Group also provides development and manufacturing services to companies in the medical devices and cosmetic sectors.

1

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

Peter Bream

2

Reason for the notification

a)

Position/status

Director

b)

Initial notification/ Amendment

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Venture Life Group plc

b)

LEI

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Identification code

Ordinary shares of 0.3p each

GB00BFPM8908

b)

Nature of the transactions

Acquisition

c)

Price(s) and volume(s)

Price(s)	Volume(s)
62p  63.5p	15,000 10,000

d)

Aggregated information

-     Aggregated volume

-     Price

25,000

62.6p

e)

Date of the transaction

7 August 2017

f)

Place of the transaction

London Stock Exchange, AIM Market

This information is provided by RNS

The company news service from the London Stock Exchange

END

DSHLLFFETLIDIID